Andy Taylor, known for his association with the band Duran Duran, has been engaged in a battle against cancer since 2018. Recently, he shared hopeful news about his health thanks to a novel treatment.
Nearly a year ago, due to his deteriorating health, Taylor was unable to attend Duran Duran’s Rock & Roll Hall of Fame induction. He sent a letter explaining his diagnosis and how proud he was to have lived long enough to witness this achievement. Following this, he was contacted by a scientist who introduced a treatment that could potentially extend his life by five years.
In an interview on BBC Breakfast, Taylor recounted the sequence of events and how a scientist named Sir Chris Evans analyzed his genomics and identified a targeted treatment, Lutetium-177, a nuclear medicine. Taylor revealed that this treatment specifically targets cancer cells and has the potential to extend his life by five years. He further noted that the treatment has been successful in combating stage four cancer in his bones.
This treatment marks a turning point for Taylor, who had been battling prostate cancer. The targeted approach of the treatment, guided by his genetic profile and specific genomic mutations in his cancer, provides him with renewed optimism and the chance to continue his creative endeavors in making and performing music. He is even releasing a new album called “Man’s a Wolf to Man” next month.
Reflecting on his journey, Taylor emphasized his determination to remain an active and working individual despite the challenges posed by cancer, offering hope to others facing similar struggles.